Kairos Pharma Files Q1 2025 10-Q
Ticker: KAPA · Form: 10-Q · Filed: May 14, 2025 · CIK: 1962011
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
Related Tickers: KAPA
TL;DR
Kairos Pharma (KAPA) filed its Q1 2025 10-Q. Financials for Q1 2025 and prior periods are available.
AI Summary
Kairos Pharma, LTD. filed its 10-Q for the period ending March 31, 2025. The company, located in Los Angeles, CA, operates in the Pharmaceutical Preparations sector. Key financial data points from previous periods are available, including common stock and retained earnings figures for fiscal years ending December 31, 2023, and 2024, as well as for the first quarters of 2024 and 2025.
Why It Matters
This filing provides investors with an update on Kairos Pharma's financial position and performance for the first quarter of 2025, crucial for assessing the company's ongoing operations and future prospects.
Risk Assessment
Risk Level: low — The filing is a standard quarterly report and does not contain immediate red flags or significant new risks.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the fiscal quarter covered by the report.)
- 2025-05-14 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
- 2024-12-31 — Previous Fiscal Year End (Provides a comparison point for the current fiscal year's performance.)
- 2023-12-31 — Prior Fiscal Year End (Offers historical financial context.)
Key Players & Entities
- Kairos Pharma, LTD. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- 20250514 (date) — Filing date
- 2355 WESTWOOD BLVD. #139 (address) — Company business and mailing address
- LOS ANGELES (location) — Company city
- 90064 (zip_code) — Company zip code
- 818-404-5541 (phone_number) — Company business phone
FAQ
What is the primary business of Kairos Pharma, LTD.?
Kairos Pharma, LTD. is in the Pharmaceutical Preparations industry, SIC code 2834.
What is the reporting period for this 10-Q filing?
The reporting period is for the quarter ended March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 14, 2025.
Where is Kairos Pharma, LTD. located?
Kairos Pharma, LTD. is located in Los Angeles, CA, with a business address at 2355 Westwood Blvd. #139, Los Angeles, CA 90064.
What are some of the financial data points mentioned for previous periods?
The filing references data for common stock, common stock to be issued, additional paid-in capital, and retained earnings for the fiscal years ending December 31, 2023, and 2024, as well as for the first quarters of 2024 and 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Kairos Pharma, LTD. (KAPA).